Evidence map›Paper›PMID 31579953›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2020

Neo-Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model.

Rudolph H Houben, Roman Thaler, Dimitra Kotsougiani, Patricia F Friedrich, Alexander Y Shin, Andre J van Wijnen, Allen T Bishop

Open access · bronzeAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rudolph H HoubenDepartment of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, 200 1st street SW55905, Building: MS-3-85, Rochester, Minnesota.ORCID 0000-0002-5205-5375
Roman ThalerDepartment of Orthopedic Surgery, Orthopedic Research Laboratory, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5515-8719
Dimitra KotsougianiDepartment of Hand-, Plastic-and Reconstructive Surgery, -Burn Center-, BG Trauma Center Ludwigshafen, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0003-2685-1105
Patricia F FriedrichORCID 0000-0002-6143-9784
Alexander Y ShinDepartment of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, 200 1st street SW55905, Building: MS-3-85, Rochester, Minnesota.ORCID 0000-0001-9658-8192
Andre J van WijnenDepartment of Orthopedic Surgery, Orthopedic Research Laboratory, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4458-0946
Allen T BishopDepartment of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, 200 1st street SW55905, Building: MS-3-85, Rochester, Minnesota.ORCID 0000-0001-9856-6448
Mayo Clinic · USHeidelberg University · DE

Funding

Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
Angiogenesis and Long-term Bone and Joint Allotransplant SurvivalR01AR049718 · NIAMS · MAYO CLINIC ROCHESTER · PI BISHOP, ALLEN T · 2003 to 2018
$4.8M
National Institute of Health R01AR049718-11A1-14NIAMS NIH HHS R01 AR049069NIAMS NIH HHS R01 AR049718
6 · The paper itself

Abstract

Vascularized composite allotransplantation of bone is a possible alternative treatment for large osseous defects but requires life-long immunosuppression. Surgical induction of autogenous neo-angiogenic circulation maintains transplant viability without this requirement, providing encouraging results in small animal models [1-3]. A preliminary feasibility study in a swine tibia model demonstrated similar findings [4, 5]. This study in swine tibial allotransplantation tests its applicability in a pre-clinical large animal model. Previously, we have demonstrated bone vascularized composite allotransplantation (VCA) survival was not the result of induction of tolerance nor an incompetent immune system [1]. Fourteen tibia vascularized bone allotransplants were microsurgically transplanted orthotopically to reconstruct size-matched tibial defects in Yucatan miniature swine. Two weeks of immunosuppression was used to maintain allotransplant pedicle patency during angiogenesis from a simultaneously implanted autogenous arteriovenous bundle. The implanted arteriovenous bundle was patent in group 1 and ligated in group 2 (a neo-angiogenesis control). At twenty weeks, we quantified the neo-angiogenesis and correlated it with transplant viability, bone remodeling, and gene expression. All patent arteriovenous bundles maintained patency throughout the survival period. Micro-angiographic, osteocyte cell count and bone remodeling parameters were significantly higher than controls due to the formation of a neo-angiogenic autogenous circulation. Analysis of gene expression found maintained osteoblastic and osteoclastic activity as well as a significant increase in expression of endothelial growth factor-like 6 (EGFL-6) in the patent arteriovenous bundle group. Vascularized composite allotransplants of swine tibia maintained viability and actively remodeled over 20 weeks when short-term immunosuppression is combined with simultaneous autogenous neo-angiogenesis. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:288-296, 2020.

Indexed as

Bone TransplantationVascularized Composite AllotransplantationAnimalsBiomarkersBone and BonesBone RemodelingGene ExpressionMaleNeovascularization, PhysiologicSwineSwine, MiniatureBiomarkersboneexperimentalneo-angiogenesisreconstructionvascularized composite allotransplantation (VCA)

Identifiers

PMID31579953
PMCPMC6980263
OpenAlexW2978074439

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.